Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gene Therapy in Oncology market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapy in Oncologymarket, defines the market attractiveness level of Gene Therapy in Oncology market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene Therapy in Oncology industry, describes the types of Gene Therapy in Oncology market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapy in Oncology market and the development prospects and opportunities of Gene Therapy in Oncology industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapy in Oncology market in Chapter 13.
By Player:
Tocagen
Marsala Biotech
Idera Pharmaceuticals
Intellia Therapeutics
Cold Genesys
Advantagene
Bio-Path Holdings
Sillajen Biotherapeutics
Bristol-Myers Squibb
UniQure
Merck
Shenzhen SiBiono GeneTech
Mologen AG
Oncosec
CRISPR Therapeutics
Editas Medicine
Oncotelic
Geron Corp
Amgen
AstraZeneca
Ziopharm Oncology
Oncolytics Biotech
Johnson & Johnson
By Type:
Ex Vivo
In Vivo
By End-User:
Hospitals
Diagnostics Centers
Research Institutes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene Therapy in Oncology Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene Therapy in Oncology Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene Therapy in Oncology Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene Therapy in Oncology Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene Therapy in Oncology Market Analysis and Outlook to 2022
-
7.1 Global Gene Therapy in Oncology Consumption (2017-2022)
-
7.2 United States Gene Therapy in Oncology Consumption (2017-2022)
-
7.3 Europe Gene Therapy in Oncology Consumption (2017-2022)
-
7.4 China Gene Therapy in Oncology Consumption (2017-2022)
-
7.5 Japan Gene Therapy in Oncology Consumption (2017-2022)
-
7.6 India Gene Therapy in Oncology Consumption (2017-2022)
-
7.7 South Korea Gene Therapy in Oncology Consumption (2017-2022)
8 Region and Country-wise Gene Therapy in Oncology Market Analysis and Outlook to 2028
-
8.1 Global Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
8.2 United States Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
8.3 Europe Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
8.4 China Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
8.5 Japan Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
8.6 India Gene Therapy in Oncology Consumption Forecast (2022-2028)
-
8.7 South Korea Gene Therapy in Oncology Consumption Forecast (2022-2028)
9 Global Gene Therapy in Oncology Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy in Oncology Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Ex Vivo Consumption and Growth Rate (2017-2022)
-
9.1.2 Global In Vivo Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy in Oncology Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diagnostics Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institutes Consumption and Growth Rate (2017-2022)
10 Global Gene Therapy in Oncology Market Outlook by Types and Applications to 2028
-
10.1 Global Gene Therapy in Oncology Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Ex Vivo Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global In Vivo Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene Therapy in Oncology Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diagnostics Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene Therapy in Oncology Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene Therapy in Oncology Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene Therapy in Oncology Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene Therapy in Oncology Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene Therapy in Oncology Market Competitive Analysis
-
14.1 Tocagen
-
14.1.1 Tocagen Company Details
-
14.1.2 Tocagen Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Tocagen Gene Therapy in Oncology Product and Service
-
14.2 Marsala Biotech
-
14.2.1 Marsala Biotech Company Details
-
14.2.2 Marsala Biotech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Marsala Biotech Gene Therapy in Oncology Product and Service
-
14.3 Idera Pharmaceuticals
-
14.3.1 Idera Pharmaceuticals Company Details
-
14.3.2 Idera Pharmaceuticals Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Idera Pharmaceuticals Gene Therapy in Oncology Product and Service
-
14.4 Intellia Therapeutics
-
14.4.1 Intellia Therapeutics Company Details
-
14.4.2 Intellia Therapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Intellia Therapeutics Gene Therapy in Oncology Product and Service
-
14.5 Cold Genesys
-
14.5.1 Cold Genesys Company Details
-
14.5.2 Cold Genesys Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Cold Genesys Gene Therapy in Oncology Product and Service
-
14.6 Advantagene
-
14.6.1 Advantagene Company Details
-
14.6.2 Advantagene Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Advantagene Gene Therapy in Oncology Product and Service
-
14.7 Bio-Path Holdings
-
14.7.1 Bio-Path Holdings Company Details
-
14.7.2 Bio-Path Holdings Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bio-Path Holdings Gene Therapy in Oncology Product and Service
-
14.8 Sillajen Biotherapeutics
-
14.8.1 Sillajen Biotherapeutics Company Details
-
14.8.2 Sillajen Biotherapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sillajen Biotherapeutics Gene Therapy in Oncology Product and Service
-
14.9 Bristol-Myers Squibb
-
14.9.1 Bristol-Myers Squibb Company Details
-
14.9.2 Bristol-Myers Squibb Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Bristol-Myers Squibb Gene Therapy in Oncology Product and Service
-
14.10 UniQure
-
14.10.1 UniQure Company Details
-
14.10.2 UniQure Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 UniQure Gene Therapy in Oncology Product and Service
-
14.11 Merck
-
14.11.1 Merck Company Details
-
14.11.2 Merck Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Merck Gene Therapy in Oncology Product and Service
-
14.12 Shenzhen SiBiono GeneTech
-
14.12.1 Shenzhen SiBiono GeneTech Company Details
-
14.12.2 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product and Service
-
14.13 Mologen AG
-
14.13.1 Mologen AG Company Details
-
14.13.2 Mologen AG Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Mologen AG Gene Therapy in Oncology Product and Service
-
14.14 Oncosec
-
14.14.1 Oncosec Company Details
-
14.14.2 Oncosec Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Oncosec Gene Therapy in Oncology Product and Service
-
14.15 CRISPR Therapeutics
-
14.15.1 CRISPR Therapeutics Company Details
-
14.15.2 CRISPR Therapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 CRISPR Therapeutics Gene Therapy in Oncology Product and Service
-
14.16 Editas Medicine
-
14.16.1 Editas Medicine Company Details
-
14.16.2 Editas Medicine Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Editas Medicine Gene Therapy in Oncology Product and Service
-
14.17 Oncotelic
-
14.17.1 Oncotelic Company Details
-
14.17.2 Oncotelic Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Oncotelic Gene Therapy in Oncology Product and Service
-
14.18 Geron Corp
-
14.18.1 Geron Corp Company Details
-
14.18.2 Geron Corp Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Geron Corp Gene Therapy in Oncology Product and Service
-
14.19 Amgen
-
14.19.1 Amgen Company Details
-
14.19.2 Amgen Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Amgen Gene Therapy in Oncology Product and Service
-
14.20 AstraZeneca
-
14.20.1 AstraZeneca Company Details
-
14.20.2 AstraZeneca Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.20.3 AstraZeneca Gene Therapy in Oncology Product and Service
-
14.21 Ziopharm Oncology
-
14.21.1 Ziopharm Oncology Company Details
-
14.21.2 Ziopharm Oncology Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.21.3 Ziopharm Oncology Gene Therapy in Oncology Product and Service
-
14.22 Oncolytics Biotech
-
14.22.1 Oncolytics Biotech Company Details
-
14.22.2 Oncolytics Biotech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.22.3 Oncolytics Biotech Gene Therapy in Oncology Product and Service
-
14.23 Johnson & Johnson
-
14.23.1 Johnson & Johnson Company Details
-
14.23.2 Johnson & Johnson Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
14.23.3 Johnson & Johnson Gene Therapy in Oncology Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene Therapy in Oncology
-
Figure Gene Therapy in Oncology Picture
-
Table Global Gene Therapy in Oncology Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy in Oncology Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy in Oncology Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene Therapy in Oncology Consumption by Country (2017-2022)
-
Figure United States Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure China Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy in Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy in Oncology Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy in Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ex Vivo Consumption and Growth Rate (2017-2022)
-
Figure Global In Vivo Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostics Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Ex Vivo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global In Vivo Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostics Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene Therapy in Oncology Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene Therapy in Oncology Export by Region (Top 5 Countries) (2017-2028)
-
Table Tocagen (Foundation Year, Company Profile and etc.)
-
Table Tocagen Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tocagen Gene Therapy in Oncology Product and Service
-
Table Marsala Biotech (Foundation Year, Company Profile and etc.)
-
Table Marsala Biotech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Marsala Biotech Gene Therapy in Oncology Product and Service
-
Table Idera Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Idera Pharmaceuticals Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Idera Pharmaceuticals Gene Therapy in Oncology Product and Service
-
Table Intellia Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Intellia Therapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intellia Therapeutics Gene Therapy in Oncology Product and Service
-
Table Cold Genesys (Foundation Year, Company Profile and etc.)
-
Table Cold Genesys Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cold Genesys Gene Therapy in Oncology Product and Service
-
Table Advantagene (Foundation Year, Company Profile and etc.)
-
Table Advantagene Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advantagene Gene Therapy in Oncology Product and Service
-
Table Bio-Path Holdings (Foundation Year, Company Profile and etc.)
-
Table Bio-Path Holdings Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Path Holdings Gene Therapy in Oncology Product and Service
-
Table Sillajen Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table Sillajen Biotherapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sillajen Biotherapeutics Gene Therapy in Oncology Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Gene Therapy in Oncology Product and Service
-
Table UniQure (Foundation Year, Company Profile and etc.)
-
Table UniQure Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table UniQure Gene Therapy in Oncology Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Gene Therapy in Oncology Product and Service
-
Table Shenzhen SiBiono GeneTech (Foundation Year, Company Profile and etc.)
-
Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product and Service
-
Table Mologen AG (Foundation Year, Company Profile and etc.)
-
Table Mologen AG Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mologen AG Gene Therapy in Oncology Product and Service
-
Table Oncosec (Foundation Year, Company Profile and etc.)
-
Table Oncosec Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncosec Gene Therapy in Oncology Product and Service
-
Table CRISPR Therapeutics (Foundation Year, Company Profile and etc.)
-
Table CRISPR Therapeutics Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table CRISPR Therapeutics Gene Therapy in Oncology Product and Service
-
Table Editas Medicine (Foundation Year, Company Profile and etc.)
-
Table Editas Medicine Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Editas Medicine Gene Therapy in Oncology Product and Service
-
Table Oncotelic (Foundation Year, Company Profile and etc.)
-
Table Oncotelic Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncotelic Gene Therapy in Oncology Product and Service
-
Table Geron Corp (Foundation Year, Company Profile and etc.)
-
Table Geron Corp Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Geron Corp Gene Therapy in Oncology Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Gene Therapy in Oncology Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Gene Therapy in Oncology Product and Service
-
Table Ziopharm Oncology (Foundation Year, Company Profile and etc.)
-
Table Ziopharm Oncology Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ziopharm Oncology Gene Therapy in Oncology Product and Service
-
Table Oncolytics Biotech (Foundation Year, Company Profile and etc.)
-
Table Oncolytics Biotech Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oncolytics Biotech Gene Therapy in Oncology Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Gene Therapy in Oncology Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Gene Therapy in Oncology Product and Service
-
